The sympathetic nervous system and obesity: Role in aetiology and treatment

Obesity Reviews

Volumn 1, Issue 1, 2000, Pages 5-15

  Snitker, S ^a   Macdonald, I ^b   Ravussin, E ^c   Astrup, A ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Autonomic nervous system; Energy expenditure; Human; Metabolism

Indexed keywords

ADRENERGIC SYSTEM; BASAL METABOLIC RATE; DIET; DRUG EFFECT; ENERGY METABOLISM; HUMAN; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; WEIGHT GAIN;

BASAL METABOLISM; DIET; ENERGY METABOLISM; HUMANS; OBESITY; SYMPATHETIC NERVOUS SYSTEM; WEIGHT GAIN;

EID: 0034179737     PISSN: 14677881     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1467-789x.2000.00001.x     Document Type: Article

References (75)

1. Astrup A, MacDonald IA. Sympathoadrenal System and Metabolism. In: Bray GA, Bouchard C, James WPT (eds). Handbook of Obesity. Marcel Dekker Inc: New York, 1998, pp 491-511.
2. Bennaroch EE. Central neurotransmitters and neuromodulators in cardiovascular regulation. In: Bannister R, Mathias CJ (eds). Autonomic Failure 3rd edn. Oxford University Press: Oxford, 1992, pp 36-53.
3. Matthews MR. Autonomic ganglia in multiple system atrophy and pure autonomic failure. In: Bannister R, Mathias CJ (eds). Autonomic Failure 3rd edn. Oxford University Press: Oxford, 1992, pp 593-621.
4. Webber J, Macdonald IA. Metabolic actions of catecholamines in man. Baillieres Clin Endocrinol Metab 1993; 7: 393-413.
5. Muntzel MS, Morgan DA, Mark AL, Johnson AK. Intracerebroventricular insulin produced non-uniform regional increases in sympathetic nerve activity. Am J Physiol 1994; 267: R1350-R1355.
6. Landsberg L, Young JB. The influence of diet on the sympathetic nervous system. Neuroendocrine Perspectives 1985; 4: 191-218.
7. Mathias CJ, Bannister R. Investigation of autonomic disorders. In: Bannister R, Mathias CJ (eds). Autonomic failure. 3rd edn. Oxford University Press: Oxford, 1992, pp 255-290.
8. Wallin BG, Sundlöf G, Lindblad LE. Baroreflex mechanisms controlling sympathetic outflow to the muscles in man. In: Sleight P (ed). Arterial Baroreceptors and Hypertension. Oxford University Press: Oxford, 1980, pp 101-108.
9. Macdonald IA. Advances in our understanding of the role of the sympathetic nervous system in obesity. Int J Obes 1995; 19: 52-57.
10. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitter to the circulation: source, fate and function. Physiol Rev 1990; 70: 963-985.
11. Kopp U, Bradley T, Hjemdahl P. Renal venous outflow and urinary excretion of norepinephrine, epinephrine and dopamine during graded renal nerve stimulation. Am J Physiol 1983; 244: E52-E60.
12. Cox HS, Kaye DM, Thompson JM, Turner AG, Jennings GL, Itsiopoulos C, Esler MD. Regional sympathetic nervous activation after a large meal in humans. Clin Sci 1995; 89: 145-154.
13. Hjemdahl P. Plasma catecholamines - analytical challenges and physiological limitations. Baillieres Clin Endocrinol Metab 1993; 7: 307-353.
14. Liu D, Andreasson K, Lins PE, Adamson U, Macdonald IA. Adrenaline and noradrenaline response to insulin-induced hypoglycaemia in men: should the hormone levels be measured in arterialised venous blood? Acta Endocrinolgica 1993; 128: 95-98.
15. Cryer PE, Rizza RA, Haymond MW, Gerich JE. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism 1980; 29: 1114-1118.
16. Macdonald IA, Webber J. Feeding, fasting and starvation: factors affecting fuel utilization. Proc Nutr Soc 1995; 54: 267-274.
17. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia. Diabetologia 1992; 35: 873-879.
18. Gelfand RA, Hutchinson-Williams KA, Bonde AA, Castellino P, Sherwin RS. Catabolic effects of thyroid hormone excess: the contribution of adrenergic activity to hypermetabolism and protein breakdown. Metabolism 1987; 36: 562-569.
19. Johnson AB, Webber J, Allison SP, Gallen IW, Mansell PI, Macdonald IA. Effects of hypothyroidism on the physiological responses to infused adrenaline. Endocrinol Metabolism 1995; 43: 747-751.
20. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, Arner P. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997; 100: 3005-3013.
21. 3 adrenergic receptor genes on basal metabolic rate in obese Finns. Diabetologia 1998; 41: 357-361.
22. Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24-hour energy expenditure in man. J Clin Invest 1986; 78: 1568-1578.
23. Bogardus C, Lillioja S, Ravussin E, Abbott W, Zawadzki JK, Young A, Knowler WC, Jacobowirz R, Moll PP. Familial dependence of the resting metabolic rate. N Engl J Med 1986; 315: 96-100.
24. Roberts SB, Savage J, Coward WA, Chew B, Lucas A. Energy intake and intake in infants born to lean and overweight mothers. N Engl J Med 1988; 318: 461-466.
25. Griffiths M, Payne PR, Stunkard AJ, Rivers JPW, Cox M. Metabolic rate and physical development in children at risk of obesity. Lancet 1990; 336: 76-77.
26. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WGH, Boyce V, Howard BV, Bogardus C. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988; 318: 467-472.
27. Astrup A, Gotzsche PC, van de Werken K, Ranneries C, Toubro S, Raben A, Buemann B. Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr 1999; 69: 1117-1122.
28. Ravussin E, Swinburn BA. Energy metabolism. In: Stunkard AJ, Wadden TA (eds). Obesity: Theory and Therapy. Raven Press: New York, 1993, pp 97-123.
29. de Jonge L, Bray GA. The thermic effect of food and obesity: a critical review. Obes Res 1997; 5: 622-631.
30. Tataranni PA, Larson DE, Snitker S, Ravussin E. Thermic effect of food in humans: methods and results from use of a respiratory chamber. Am J Clin Nutr 1995; 61: 1013-1019.
31. Zurlo F, Ferraro RT, Fontvieille AM, Rising R, Bogardus C, Ravussin E. Spontaneous physical activity and obesity: cross-sectional and longitudinal studies in Pima Indians. Am J Physiol 1992; 263: E296-E300.
32. Zurlo F, Lillioja S, Esposito-del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogardus C, Ravussin E. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol 1990; 259: E650-E657.
33. Seidell JC, Muller DC, Sorkin JD, Andres R. Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Ageing. Int J Obes Relat Metab Disord 1992; 16, 667-674.
34. Astrup A, Buemann B, Christensen NJ, Toubro S. Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am J Physiol 1994; 266: E592-E599.
35. Larson DE, Ferraro RT, Robertson DS, Ravussin E. Energy metabolism in weight-stable postobese individuals. Am J Physiol 1995; 62: 735-739.
36. Acheson KJ, Ravussin E, Schoeller DA, Christin L, Bourquin L, Baertschi E, Danforth E Jr, Jéquier E. Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twenty four-hour energy expenditure. Metabolism 1988; 37: 91-98.
37. Saad MF, Alger SA, Zurlo F, Young JB, Bogardus C, Ravussin E. Ethnic differences in sympathetic nervous system-mediated energy expenditure. Am J Physiol 1991; 261: E789-E784.
38. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92: 1730-1735.
39. Poehlman ET, Arciero PJ, Goran MI. Endurance exercise in ageing humans: effects on energy metabolism. Exercise Sports Sci Rev 1994; 22: 251-284.
40. Toth MJ, Poehlman ET. Sympathetic nervous system activity and resting metabolic rate in vegetarians. Metabolism 1994; 43: 621-625.
41. Schwartz RS, Jaeger LF, Veith RC. Sympathetic nervous activity and the thermic effect of feeding in man. Int J Obes Relat Metab Disord 1987; 11: 141-149.
42. Schwartz RS, Jaeger LF, Veith RC. The termic effect of feeding in older men: the effect of the sympathetic nervous system. Metabolism 1990; 39: 733-737.
43. Anderson EA, Hoffman PP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87: 2246-2252.
44. Christin L, O'Connell M, Bogardus C, Danforth E Jr, Ravussin E. Norepinephrine turnover and energy expenditure in Pima Indian and White men. Metabolism 1993; 42: 723-729.
45. Snitker S, Tataranni PA, Ravussin E. Respiratory quotient is inversely associated with muscle sympathetic nerve activity. J Clin Endocrinol Metab 1998; 83: 3977-3979.
46. Blaak EE, van Baak MA, Kemerink GJ, Pakbiers MTW, Heidendal GAK, Saris WHM. β-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. Am J Physiol 1994; 267: E316-E322.
47. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T. Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998; 83: 2441-2444.
48. Piétri-Rouxel F, St John Manning B, Gros J, Strosberg AD. The biochemical effect of the naturally occurring Trp64 > Arg mutation on human β3-adrenoceptor activity. Eur J Biochem 1997; 274: 1174-1179.
49. Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD. Pharmacological characterization of a recently described human beta 3- adrenergic receptor mutant. Endocrinology 1996; 137, 2638-2641.
50. Bouchard C, Perusse L, Chagnon YC, Warden C, Riquier D. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Gen 1997; 11, 1887-1889.
51. Argyropoulos G, Brown AM, Willi SM, Zhu J, He Y, Reitman M, Gevao SM, Spruill I, Garvey TG. Effects of mutations in the human uncoupling protein 3 gene on respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest 1998; 102, 1345-1351.
52. Young JB, Macdonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980 Int J Obes Relat Metab Disord 1992; 16: 959-967.
53. Tataranni PA, Young JB, Bogardus C, Ravussin E. A low sympathetic nervous system activity is associated with body weight gain in Pima Indians. Obes Res 1997; 5: 341-347.
54. Raben A, Holst JJ, Christensen NJ, Astrup A. Determinants of postprandial appetite sensations: macronutrient intake and glucose metabolism. Int J Obes 1996; 20: 161-169.
55. Astrup A, Christensen NJ, Simonsen L, Bülow J. Effects of nutrient intake on sympathoadrenal activity and thermogenic mechanisms. J Neurosci Methods 1990; 34: 187-192.
56. Astrup A, Buemann B, Gluud C, Bennett P, Tjur T, Christensen NJ. Prognostic markers for diet-induced weight loss in obese women. Int J Obes 1995; 19: 275-278.
57. Kempen KPG. Predictors of fat loss during very-low caloric diet in obese females. Ph.D. thesis, University of Maastricht, Holland, 1996.
58. 2-adrenoceptor sensitivity - a metabolic predictor of weight loss in obese subjects. Int J Obes 1995; 21: 314-320.
59. Astrup A, Lundsgaard C. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice. Exp Clin Endocrinol Diabetes 1998; 106: 29-34.
60. Astrup A, Toubro S, Raben A, Skov AR. The role of low fat diets and fat substitutes in body weight management: What have we learned from clinical studies? J Am Diet Assoc 1997; 97: S82-S87.
61. Raben A, Macdonald I, Astrup A. Replacement of dietary fat by sucrose or starch: effects on 14 days' ad libitum energy intake, energy expenditure and body weight in formerly obese and never-obese subjects. Int J Obes 1997; 21: 846-859.
62. Vasilaras TH, Raben A, Astrup A. Abstract no P605. Six months intake of simple carbohydrates increases energy expenditure obese subjects. Int J Obes 1998; 22: S256.
63. Tappy L, Randin J-P, Felber J-P, Chiolero R, Simonsen DC, Jécquier E, DeFonzo RA. Comparison of thermogenic effect of fructose and glucose in normal humans. Am J Physiol 1986; 250: E718-E724.
64. Raben A, Kiens B, Richter EA. Differences in glycaemia, hormonal response and energy expenditure after a meal rich in mono-and disaccharides compared to a meal rich in polysaccharides in physically fit and sedentary subjects. Clin Phys 1994; 14: 267-280.
65. Yen TT. β-agonists as antiobesity, antidiabetic and nutrient partitioning agents. Obes Res 1995; 3: 531S-6S.
66. 3-agonist ZD2079 stimulates. 24-hour energy expenditure through increased fidgeting. A 14-day, randomized placebo-controlled study in obese subjects. Int J Obes 1995; 19: abstract 070.
67. 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans. Int J Obes 1995; 19: 678-685.
68. Astrup A, Breum L, Toubro S, Hein P, Quaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int J Obes 1992; 16: 269-277.
69. Toubro S, Astrup A, Breum L, Quaade F. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Int J Obes 1993; 17: S69-S72.
70. Astrup A, Toubro S, Cannon S, Hein P, Madsen J. Thermogenic synergism between ephedrine and caffeine in healthy volunteers. A double blind placebo-controlled study. Metabolism 1991; 40: 323-329.
71. Weintraub M, Rubio A, Golik A, Byrne L, Scheinbaum ML. Sibutramine in weight control: a dose-ranging, efficacy study. Clin Pharmacol Ther 1991; 50: 330-337.
72. Hansen DL, Toubro S, Stcok MJ, Macdonald IA, Astrup A. Thermogenic effects of sibutramine in humans. Am J Clin Nutr 1998; 68: 1180-1186.
73. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. Thermogenic effect of sibutramine during chronic treatment withour dietary restriction in obese subjects. Int J Obes 1999; 23: 1016-1024.
74. Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F, Mancia G. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97: 2037-2042.
75. Hansen DL. The effect of sibutramine on energy balance. Ph.D. thesis, The Royal Veterinary and Agricultural University, Frederiksberg, Denmark. DSR, Copenhagen, Denmark, 1998.